Tag: Diabetes: Drugs
Dasiglucagon Well Tolerated for Severe Hypoglycemia
Early pharmacodynamic response similar to that of GlucaGen, with longer lasting effects plasma glucose
Adherence to T2DM Treatment Varies Across Medication Classes
Adherence better for sulfonylureas and thiazolidinediones compared with metformin
Fat Intake Influences HbA1c-Lowering Effect in DPP4i Therapy
Saturated fat intake is significantly correlated with change in HbA1c during DPP4i monotherapy
First-Line Metformin Use for DM Up; Sulfonylurea Use Down
But sulfonylureas still most common drugs initiated as second-line treatment
Venovenous Hemodiafiltration Improves Metformin Toxicity
Case report describes treatment of female patient who attempted suicide with metformin overdose
Glyburide, Metformin Have Similar Effect in Gestational DM
High efficacy rate for both glyburide, metformin; combo of drugs significantly reduces need for insulin
Varying Safety of Add-On Second-Line T2DM Treatments
For patients taking metformin, TZD and DPP-4i linked to lower mortality, cardiovascular risks
ADA: Liraglutide Lowers Risk for Cardiovascular Events in T2DM
Daily, injected medication shows 'encouraging' results in international trial
High-Dose Metformin Linked to Increases in Child Height
Dose-response relationship between metformin use and increases in height in children, teens
FDA Approves Two New Medications for Diabetes
Tresiba and Ryzodeg approved for use in adults with type 1 and 2 diabetes mellitus
